SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010767
Filing Date
2024-08-05
Accepted
2024-08-05 07:00:44
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q epix-20240630x10q.htm   iXBRL 10-Q 1543074
2 EX-31.1 epix-20240630xex31d1.htm EX-31.1 7128
3 EX-31.2 epix-20240630xex31d2.htm EX-31.2 7118
4 EX-32.1 epix-20240630xex32d1.htm EX-32.1 9205
5 GRAPHIC epix-20240630x10q001.jpg GRAPHIC 17235
6 GRAPHIC epix-20240630x10q003.jpg GRAPHIC 38174
7 GRAPHIC epix-20240630x10q004.jpg GRAPHIC 38064
  Complete submission text file 0001558370-24-010767.txt   5738499

Data Files

Seq Description Document Type Size
8 EX-101.SCH epix-20240630.xsd EX-101.SCH 36441
9 EX-101.CAL epix-20240630_cal.xml EX-101.CAL 37262
10 EX-101.DEF epix-20240630_def.xml EX-101.DEF 107353
11 EX-101.LAB epix-20240630_lab.xml EX-101.LAB 301149
12 EX-101.PRE epix-20240630_pre.xml EX-101.PRE 216190
65 EXTRACTED XBRL INSTANCE DOCUMENT epix-20240630x10q_htm.xml XML 897496
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 241173073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)